{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T08:18:19Z","timestamp":1782807499232,"version":"3.54.5"},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["canadianjournalofophthalmology.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.jcjo.2012.09.001","type":"journal-article","created":{"date-parts":[[2013,10,4]],"date-time":"2013-10-04T15:21:12Z","timestamp":1380900072000},"page":"493-499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Fluoroquinolones or fortified antibiotics for treating bacterial keratitis: systematic review and meta-analysis of comparative studies"],"prefix":"10.1016","volume":"47","author":[{"given":"Marie-Sophie","family":"Hanet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Jamart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Pinheiro Chaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjo.2012.09.001_bib1","unstructured":"American Academy of Ophthalmology. Cornea\/External Disease Panel. Bacterial keratitis. Preferred Practice Patterns. Limited revision Oct. 2011. Available at www.aao.org\/ppp. Accessed November 1, 2012."},{"key":"10.1016\/j.jcjo.2012.09.001_bib2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ajo.2003.09.001","article-title":"Clinical characteristics of microbial keratitis in a university hospital in Taiwan","volume":"137","author":"Fong","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2012.09.001_bib3","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1136\/bjo.87.7.834","article-title":"Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases","volume":"87","author":"Bourcier","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcjo.2012.09.001_bib4","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0002-9394(03)00294-0","article-title":"Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates","volume":"136","author":"Kowalski","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2012.09.001_bib5","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1001\/archopht.1995.01100100045026","article-title":"Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis: report from the Bacterial Keratitis Study Research Group","volume":"113","author":"O\u2019Brien","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jcjo.2012.09.001_bib6","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/S0161-6420(96)30416-8","article-title":"Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group","volume":"103","author":"Hyndiuk","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2012.09.001_bib7","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/S0161-6420(97)30009-8","article-title":"Ofloxacin monotherapy for the primary treatment of microbial keratitis: a double-masked, randomized, controlled trial with conventional dual therapy. The Ofloxacin Study Group","volume":"104","author":"Pavesio","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2012.09.001_bib8","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/eye.1999.220","article-title":"Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis","volume":"13","author":"Panda","year":"1999","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.jcjo.2012.09.001_bib9","first-page":"S83","article-title":"Clinical evaluation of ophthalmic lomefloxacin 0.3% in comparison with fortified cefazolin and gentamicin ophthalmic solutions in the treatment of presumed bacterial keratitis","volume":"87","author":"Erjongmanee","year":"2004","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.jcjo.2012.09.001_bib10","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.ophtha.2006.12.011","article-title":"Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis. A randomized clinical trial","volume":"114","author":"Constantinou","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2012.09.001_bib11","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/ICO.0b013e3181ca2ba3","article-title":"Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers","volume":"29","author":"Shah","year":"2010","journal-title":"Cornea"},{"key":"10.1016\/j.jcjo.2012.09.001_bib12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5372\/1905-7415.0501.009","article-title":"The efficacy and safety of 0.5% levofloxacin versus fortified cefazolin and amikacin ophthalmic solution for the treatment of suspected and culture proven cases of infectious bacterial keratitis: a comparative study","volume":"5","author":"Kasetsuwan","year":"2011","journal-title":"Asian Biomedicine"},{"key":"10.1016\/j.jcjo.2012.09.001_bib13","first-page":"34S","article-title":"Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis","volume":"112","author":"Leibowitz","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2012.09.001_bib14","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/archopht.1993.01090090062020","article-title":"0.3% ciprofloxacin ophthalmic ointment in the treatment of bacterial keratitis. The Ciprofloxacin Ointment\/Bacterial Keratitis Study Group","volume":"111","author":"Wilhelmus","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jcjo.2012.09.001_bib15","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0002-9394(14)74449-6","article-title":"Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of ulcerative keratitis","volume":"115","author":"Parks","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2012.09.001_bib16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1442-9071.2006.01143.x","article-title":"Bacteria commonly isolated from keratitis specimens retain antibiotic susceptibility to fluoroquinolones and gentamicin plus cephalothin","volume":"34","author":"Ly","year":"2006","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.jcjo.2012.09.001_bib17","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/bjo.84.4.378","article-title":"Fluoroquinolone and fortified antibiotics for treating bacterial corneal ulcers","volume":"84","author":"Gangopadhyay","year":"2000","journal-title":"Br J Ophtalmol"},{"key":"10.1016\/j.jcjo.2012.09.001_bib18","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"10.1016\/j.jcjo.2012.09.001_bib19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0002-9394(00)00642-5","article-title":"Increased incidence of corneal perforation after topical fluoroquinolone treatment for microbial keratitis","volume":"131","author":"Mallari","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2012.09.001_bib20","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ajo.2007.06.038","article-title":"Antibiotic susceptibility of bacterial isolates from bacterial keratitis cases in a university hospital in Taiwan","volume":"144","author":"Fong","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2012.09.001_bib21","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/00003226-200003000-00014","article-title":"Effect of fortified antibiotic solutions on corneal epithelial wound healing","volume":"19","author":"Lin","year":"2000","journal-title":"Cornea"},{"key":"10.1016\/j.jcjo.2012.09.001_bib22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1444-0938.2010.00536.x","article-title":"Review of resistance of ocular isolates of Pseudomonas aeruginosa and staphylococci from keratitis to ciprofloxacin, gentamicin and cephalosporins","volume":"94","author":"Willcox","year":"2011","journal-title":"Clin Exp Optom"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418212004231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418212004231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T20:01:57Z","timestamp":1757793717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008418212004231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0008418212004231"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjo.2012.09.001","relation":{},"ISSN":["0008-4182"],"issn-type":[{"value":"0008-4182","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluoroquinolones or fortified antibiotics for treating bacterial keratitis: systematic review and meta-analysis of comparative studies","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjo.2012.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}